<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In a recent paper in Cell, Oricchio etÂ al. identify EPHA7 as a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene residing in the 6q-deleted region in follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>A truncated EPHA7(TR) isoform is secreted by <z:mpath ids='MPATH_458'>normal</z:mpath> B cells, inhibits EPHA2 signaling, and, as a secreted <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor protein, has potential as a targeted therapeutic <z:chebi fb="1" ids="15841">polypeptide</z:chebi> </plain></SENT>
</text></document>